Concepedia

Roya Dadmarz

RD

8

Publications

383

Citations

8

H-Index

1987

Active since

Affiliations

National Institutes of Health(Current)

University College London

National Cancer Institute

Dana-Farber Cancer Institute

Roya Dadmarz is an author at National Institutes of Health specializing in autoimmunity, immunotherapy, and immunology.

Top concepts

Publications per year

1987–2006

8

Publications

8

In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2.

Douglas J. Schwartzentruber, Sophia S. Hom, Roya Dadmarz et al. · Journal of Clinical Oncology · 1994 · 158 citations

CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion

Roya Dadmarz, Magdalene K. Sgagias, Steven A. Rosenberg et al. · Cancer Immunology Immunotherapy · 1995 · 58 citations · Full text

, , +12

Heterogeneity of CLL: high CD23 antigen and αIFN receptor expression are features of favourable disease and of cell activation

Roya Dadmarz, John C. Cawley · British Journal of Haematology · 1988 · 58 citations

, , +25

Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashion.

Roya Dadmarz, A Ordoubadi, Arnold Mixon et al. · PubMed · 2006 · 55 citations

Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.

Roya Dadmarz, David Bockstoce, Sidney H. Golub · PubMed · 1994 · 16 citations

, , +17

Rows per page

1–5 of 8